Jagannadham Thununguntla, Strategist & Head of Research, SMC Global Securities Limited is of the view that Glenmark Pharma will continue to be a decent performer.
first published: Apr 9, 2013 03:45 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

